INJ pipzo pediatric dose
piperacillin tazobactam pediatric dosing guidelines 2025
Doses below are expressed as the piperacillin component unless otherwise stated.
| Age Group | Dose | Frequency |
|---|---|---|
| Neonates | 160-300 mg/kg/day | Divided q8-12h (2-4 doses/day) |
| Infants 2-9 months | 90 mg/kg/dose | q8h (intra-abdominal) or q6h (nosocomial pneumonia) |
| Children >9 months / 2-12 yrs (≤40 kg) | 100 mg/kg/dose | q8h (standard) |
| Severe infections | 100 mg/kg/dose | q6h |
| Children >40 kg / adolescents | Use adult dosing: 3.375-4.5 g | q6-8h |
| Indication | Dose | Source |
|---|---|---|
| Intra-abdominal infection (2-12 yrs, ≤40 kg) | 100 mg/kg/dose q8h | Pfizer/FDA label |
| Febrile neutropenia (<50 kg) | 80 mg/kg/dose q6h (with aminoglycoside) | Pfizer label |
| Skin/Soft tissue / Necrotizing fasciitis | 60-75 mg/kg/dose q6h | IDSA 2014 Guidelines |
| Endocarditis (children) | 240 mg/kg/day in divided doses q8h | AHA Guidelines |
| Surgical prophylaxis | Per ASHP/IDSA/SIS/SHEA weight-based protocol | - |
| eGFR (mL/min/1.73m²) | Standard Dose Adjustment | Severe Infection Adjustment |
|---|---|---|
| ≥40 | Normal dosing | Normal dosing |
| 20-40 | 70 mg/kg/dose q8h | 50-70 mg/kg/dose q6h |
| <20 | 70 mg/kg/dose q12h | 50-70 mg/kg/dose q8h |